13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001447228
Total reported value
$291.3M
$291.3M
22 檔
327.0%
According to the latest 13F quarterly dataset, Yiheng Capital Management, L.P. managed an equity portfolio of $291.3M at the end of Q1 2025, spanning 22 distinct U.S. exchange-listed positions.
In Q1 2025, Yiheng Capital Management, L.P. adopted a defensive or profit-taking posture, trimming 6 positions and completely liquidating 17 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including JD, BILI, NOAH) accounted for 327.0% of total reported equity market value during Q1 2025.
Top New Position Initiated
ALAB
市值: $49.9M
Top Position Liquidated / Trimmed
TDG
前期市值: $169.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | JD | Jd.com Inc-adr | Stock-Consumer Disc | 50.29% | +5.02% | -67.10% | |
| 2 | BILI | Bilibili Inc-sponsored Adr | Stock-Other | 23.54% | +5.11% | -68.61% | |
| 3 | NOAH | Noah Holdings Ltd-spon Ads | Stock-Other | 5.90% | -5.79% | — | |
| 4 | ALAB | Astera Labs Inc | Stock-Tech | 4.64% | — | +2.22% | |
| 5 | AKRO | Akero Therapeutics Inc | Stock-Other | 4.18% | — | +66.82% | |
| 6 | EDU | New Oriental Educatio-sp Adr | Stock-Consumer Staples | 2.66% | +1.79% | +15.39% | |
| 7 | HTHT | H World Group Ltd-adr | Stock-Other | 2.22% | -2.42% | -50.58% | |
| 8 | RBLX | Roblox CORP -class A | Stock-Comm Services | 1.53% | — | -50.75% | |
| 9 | RERE | Atrenew Inc | Stock-Other | 0.86% | -2.23% | — | |
| 10 | VRDN | Viridian Therapeutics Inc | Stock-Other | 0.63% | +0.76% | -33.32% | |
| 11 | ACMR | Acm Research Inc-class A | Stock-Other | 0.61% | — | -58.83% | |
| 12 | DNLI | Denali Therapeutics Inc | Stock-Other | 0.59% | — | -32.87% | |
| 13 | IVA | Inventiva SA - Adr | Stock-Other | 0.53% | — | — | |
| 14 | SVCO | Silvaco Group Inc | Stock-Other | 0.43% | +0.93% | — | |
| 15 | DBVT | Dbv Technologies Sa-spon Adr | Stock-Other | 0.42% | -0.58% | — | |
| 16 | TAL | Tal Education Group- Adr | Stock-Consumer Staples | 0.38% | -1.25% | -85.86% | |
| 17 | KYMR | Kymera Therapeutics Inc | Stock-Other | 0.31% | -0.15% | — | |
| 18 | BEAM | Beam Therapeutics Inc | Stock-Other | 0.13% | +0.03% | -83.79% | |
| 19 | API | Agora Inc-adr | Stock-Other | 0.07% | -0.12% | — | |
| 20 | YSG | Yatsen Holding Ltd-adr | Stock-Other | 0.04% | -0.04% | +816.71% | |
| 21 | TOUR | Tuniu Corp-spon Adr | Stock-Other | 0.03% | -0.10% | EXIT | |
| 22 | GBIOGBX | Generation Bio Co | Stock-Other | 0.01% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | JD | Jd.com Inc-adr | +43.1% | -67.10% | Add |
| 2 | AKRO | Akero Therapeutics Inc | +2.7% | +66.82% | Trim |
| 3 | IVA | Inventiva SA - Adr | +0.5% | — | Add |
| 4 | RERE | Atrenew Inc | -0.2% | — | Add |
| 5 | BILI | Bilibili Inc-sponsored Adr | -0.3% | -68.61% | Add |
| 6 | TOUR | Tuniu Corp-spon Adr | -0.6% | — | Trim |
| 7 | GBIOGBX | Generation Bio Co | -1.5% | — | Trim |
| 8 | ACMR | Acm Research Inc-class A | -2.9% | -58.83% | Trim |
| 9 | HTHT | H World Group Ltd-adr | -4.3% | -50.58% | Trim |
| 10 | TAL | Tal Education Group- Adr | -5.5% | -85.86% | Trim |
| 11 | NOAH | Noah Holdings Ltd-spon Ads | -6.7% | — | Add |
| 12 | TDG | Transdigm Group Inc | — | EXIT | Sold out |
| 13 | HIMX | Himax Technologies Inc-adr | — | EXIT | Sold out |
| 14 | SABR | Sabre CORP | — | EXIT | Sold out |
| 15 | SIMO | Silicon Motion Technol-adr | — | EXIT | Sold out |
| 16 | NIU | Niu Technologies-spons Adr | — | EXIT | Sold out |
| 17 | ALAB | Astera Labs Inc | — | NEW | New buy |
| 18 | GBTUSD | Global Blood Therapeutics In | — | EXIT | Sold out |
| 19 | ✓ | Hollysys Automation Tchngy L | — | EXIT | Sold out |
| 20 | OPHTEUR | Iveric Bio Inc | — | EXIT | Sold out |
| 21 | JOYY | Joyy Inc-adr | — | EXIT | Sold out |
| 22 | EDU | New Oriental Educatio-sp Adr | — | NEW | New buy |
| 23 | PETQEUR | Petiq Inc | — | EXIT | Sold out |
| 24 | MOMOUSD | Momo Inc-spon Adr | — | EXIT | Sold out |
| 25 | RBLX | Roblox CORP -class A | — | NEW | New buy |
| 26 | VECO | Veeco Instruments Inc | — | EXIT | Sold out |
| 27 | ✓ | Onesmart Intl Ed Group LTD | — | EXIT | Sold out |
| 28 | VRDN | Viridian Therapeutics Inc | — | NEW | New buy |
| 29 | DNLI | Denali Therapeutics Inc | — | NEW | New buy |
| 30 | ULCC | Frontier Group Holdings, Inc. | — | EXIT | Sold out |
| 31 | ✓ | Ryb Ed Inc | — | EXIT | Sold out |
| 32 | SVCO | Silvaco Group Inc | — | NEW | New buy |
| 33 | DBVT | Dbv Technologies Sa-spon Adr | — | NEW | New buy |
| 34 | SQNS | Sequans Communications S.A. | — | EXIT | Sold out |
| 35 | KYMR | Kymera Therapeutics Inc | — | NEW | New buy |
| 36 | BEAM | Beam Therapeutics Inc | — | NEW | New buy |
| 37 | BIRD | Smartbird, Inc | — | EXIT | Sold out |
| 38 | API | Agora Inc-adr | — | NEW | New buy |
| 39 | YSG | Yatsen Holding Ltd-adr | — | NEW | New buy |
According to official SEC Form 13F filings, Yiheng Capital Management, L.P. reported a total U.S. public equity portfolio value of $291.3M across 22 disclosed positions in Q1 2025.
During Q1 2025, Yiheng Capital Management, L.P.'s top holdings by market value included JD (50.3%)、BILI (23.5%)、NOAH (5.9%). The largest single position, JD, represented 50.3% of total portfolio value.
In Q1 2025, Yiheng Capital Management, L.P. made 39 total portfolio adjustments, initiating 11 new buys, adding to 5 positions, trimming 6 holdings, and fully liquidating 17 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.